---
title: "Guotai Group released its first-quarter performance, with a net profit attributable to the parent company of 43.08 million yuan, a year-on-year decrease of 8.23%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237886237.md"
description: "According to the Zhitong Finance APP, Guotai Group disclosed its first-quarter report for 2025, showing that the company achieved revenue of 483 million yuan during the reporting period, a year-on-year decrease of 1.26%; net profit attributable to shareholders was 43.08 million yuan, a year-on-year decrease of 8.23%; and net profit excluding non-recurring items was 39.66 million yuan, a year-on-year increase of 17.09%. Basic earnings per share were 0.07 yuan"
datetime: "2025-04-28T14:39:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237886237.md)
  - [en](https://longbridge.com/en/news/237886237.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237886237.md)
generator: "portal-rs"
---

# Guotai Group released its first-quarter performance, with a net profit attributable to the parent company of 43.08 million yuan, a year-on-year decrease of 8.23%

According to the Zhitong Finance APP, Guotai Group (603977.SH) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 483 million yuan, a year-on-year decrease of 1.26%; net profit attributable to the parent company was 43.08 million yuan, a year-on-year decrease of 8.23%; and net profit excluding non-recurring gains and losses was 39.66 million yuan, a year-on-year increase of 17.09%. Basic earnings per share were 0.07 yuan

### Related Stocks

- [603977.CN](https://longbridge.com/en/quote/603977.CN.md)

## Related News & Research

- [APT Medical: H1 2026 revenue and profit rose over 25% year-over-year, with strong growth in core segments](https://longbridge.com/en/news/296363764.md)
- [TABLE-Asian physical rubber prices - August 19](https://longbridge.com/en/news/296318042.md)
- [Ata Turizm Discloses High Non-Compliant Income Under Participation Finance Rules](https://longbridge.com/en/news/296522750.md)
- [LongBio Pharma says China regulator accepts LP-003 BLA for seasonal allergic rhinitis](https://longbridge.com/en/news/296541366.md)
- [ANALYSIS-Can nicotine pouches drive Big Tobacco's future beyond cigarettes?](https://longbridge.com/en/news/296178056.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**